Direkt zum Inhalt | Direkt zur Navigation

Link zur Österreich Version Link to English Version
  • A
  • A
  • A
Sie sind hier: Startseite EbM EVENTS Veranstaltungskalender Lost in the Maze? Navigating Evidence and Ethics in Translational Neuroscience

Lost in the Maze? Navigating Evidence and Ethics in Translational Neuroscience

The Herrenhausen Conference on February 14-16, 2018 in Hannover focuses on new treatment modalities of novel neurological interventions in the light of the ethical challenges concerning the personal despair.

Was Konferenz
Wann 14.02.2018 to
Wo Hannover
AnsprechpartnerIn Dr. Oliver Grewe
Telefon +49 (0)511 8381-252
Sponsoren VolkswagenStiftung

This Herrenhausen Conference focuses on major scientific and ethical challenges of novel neurological interventions and how they can be overcome. Participants will explore how critically needed trials of new treatment modalities can be launched safely and conducted ethically.

Since most major neurological disorders like Alzheimer's, traumatic brain injuries, Amyothrophic Lateral Sclerosis, and many others have no cure, the despair of patients means they often fail to consider the major risks intrinsic to early clinical trials of novel modalities such as stem cell interventions and gene therapy. While these new pathways to potential treatments need to be pursued, they are being developed in a climate that often is not conducive to good science. Factors such as concerns about irreproducible research results, researchers' needs to divide their time between their research and pursuing funding, and the inflated expectations produced by science hype can all hinder efforts to conduct investigations carefully and responsibly. To help improve this problematic climate, the Herrenhausen Conference will address:

  1. The personal despair and public hype that frame contemporary scientific research in neurological disease.
  2. Deficiencies in pre-clinical neurological research and how to overcome them in order to increase the safety and predictive value of early trials of novel neurological interventions.
  3. Strategies that can improve the informed consent processes for trials of these novel interventions.

Weitere Informationen über diesen Termin…

Zuletzt verändert: 24.11.2017